Advertisement

Assessment of Fracture Risk

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Rheumatic Disease Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. National Osteoporosis Foundation, Clinician’s guide to prevention and treatment of osteoporosis. 2008. Available at: http://www.nof.org/professionals/NOF_clinicians_Guide.pdf. Accessed February 12, 2011.

        • Burge R.
        • Dawson-Hughes B.
        • Solomon D.H.
        • et al.
        Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025.
        J Bone Miner Res. 2007; 3: 465-475
      2. World Health Organization (1994) assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series 843.
        WHO, Geneva (Switzerland)1994
        • Kanis J.A.
        • Melton L.J.
        • Christiansen C.
        • et al.
        The diagnosis of osteoporosis.
        J Bone Miner Res. 1994; 9: 1137-1141
        • Kanis J.A.
        • Johnell O.
        • Oden A.
        • et al.
        Risk of hip fracture according to the World Health Organization criteria for osteoporosis and osteopenia.
        Bone. 2000; 27: 585-590
      3. World Health Organization guidelines for preclinical evaluation and clinical trials in osteoporosis.
        WHO, Geneva (Switzerland)1998
        • Marshall D.
        • Johnell O.
        • Edel H.
        Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.
        BMJ. 1996; 312: 1254-1259
        • Cooper C.
        • Aihie A.
        Osteoporosis: recent advances in pathogenesis and treatment.
        QJM. 1994; 87: 203-209
        • Kanis J.A.
        • Borgstrom F.
        • De Laet C.
        • et al.
        Assessment of fracture risk.
        Osteoporos Int. 2005; 16: 581-589
        • Wainwright S.A.
        • Marshall L.M.
        • Ensrud K.E.
        • Study of Osteoporotic Fractures Research Group
        • et al.
        Hip fractures in women without osteoporosis.
        J Clin Endocrinol Metab. 2005; 90: 2787-2793
        • Pasco J.A.
        • Seeman E.
        • Henry M.J.
        • et al.
        The population burden of fractures originates in women with osteopenia, not osteoporosis.
        Osteoporos Int. 2006; 17: 1404-1409
        • Sornay-Rendu E.
        • Muoz F.
        • Garnero P.
        • et al.
        Identification of osteopenic women at high risk of fracture. The OFELY study.
        J Bone Miner Res. 2005; 20: 813-1819
        • Kanis J.A.
        • McCloskey E.V.
        • Johansson H.
        • et al.
        Development and use of FRAX® in osteoporosis.
        Osteoporos Int. 2010; 21: S407-S413
        • Papaionnou A.
        • Morin S.
        • Cheung A.M.
        • et al.
        2010 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.
        CMAJ. 2010; 182: 1864-1873
        • Hamdy R.C.
        • Baim S.
        • Broy S.B.
        Algorithm for the management of osteoporosis.
        SMJ. 2010; 103: 1009-1015
      4. FRAX® Available at: http://www.sheffield.ac.uk/FRAX/index.jsp. Accessed February 24, 2011.

      5. World Health Organization. Assessment of osteoporosis at the primary health care level. WHO, Geneva (Switzerland), 2007. Available at: www.who.int/chp/topics/rheumatic/en/index.html. Accessed February 23, 2011.

        • Nguyen N.D.
        • Frost S.A.
        • Center J.R.
        • et al.
        Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks.
        Osteoporos Int. 2008; 19 (Available at:) (Accessed February 24, 2011): 1431-1444
        • Hippisley-Cox J.
        • Copuland C.
        Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores.
        BMJ. 2009; 339 (Available at:) (Accessed February 24, 2011): b4229
      6. Kanis JA on behalf of the World Health Organization Scientific Group a, Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield. UK; 2008. Available at: http://www.shef.ac.uk/FRAX/index.htm. Accessed February 24, 2011.

        • Oden A.
        • Johansson H.
        • McCloskey E.V.
        FRAX™ and the assessment of fracture probability in men and women from the UK.
        Osteoporos Int. 2008; 19: 385-397
        • Kanis J.A.
        • Johnell O.
        • Oden A.
        • et al.
        FRAX and the assessment of fracture probability in men and women from the UK.
        Osteoporos Int. 2008; 19: 385-397
      7. FRAX. Available at: http://www.shef.ac.uk//FRAX. Accessed February 23, 2011.

        • Kanis J.A.
        • Oden A.
        • Johnell O.
        • et al.
        The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.
        Osteoporos Int. 2007; 18: 1033-1046
        • Schousboe J.T.
        • Vokes T.
        • Broy S.B.
        • et al.
        Vertebral fracture assessment, The 2007 Official Positions.
        JCD. 2008; 11: 92-108
      8. Available at: http://itunes.apple.com/us/app/frax/id370146412?mt=8. Accessed February 24, 2011.

      9. Available at: http://www.shef.ac.uk/FRAX/charts.jsp. Accessed February 24, 2011.

        • Hans D.
        • Kanis J.
        • Baim S.
        • et al.
        Joint official positions of the International Society for Clinical Densitometry (ISCD) and International Osteoporosis Foundation (IOF) on FRAX®: executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX® in Clinical Practice.
        J Clin Densitom. 2011; ([Epub ahead of print])
        • Kanis J.
        • Hans D.
        • Cooper C.
        • et al.
        Interpretation and use of FRAX® in clinical practice.
        Osteoporos Int. 2011; (Epub)
        • Leslie W.D.
        • Lix L.M.
        • Johansson H.
        • et al.
        Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.
        J Bone Miner Res. 2010; 25: 2350-2358
        • Fraser L.-A.
        • Langsetmo L.
        • Berger C.
        • et al.
        Fracture prediction and calibration of a Canadian FRAX tool: a population-based report from CaMos.
        Osteoporos Int. 2011; 22: 829-837
      10. FRAX implementation guide. Available at: http://www.nof.org/sites/default/files/pdfs/nof_FRAX_Implem_Guide.pdf. Accessed February 24, 2011.

      11. FRAX implementation guide. Available at: http://www.iscd.org/visitors/pdfs/FRAXimplementationGuide_000.pfd. Accessed February 24, 2011.

        • Watts N.B.
        • Siris E.S.
        • Cummings S.R.
        • et al.
        Perspective: filtering FRAX®.
        Osteoporos Int. 2010; 21: 537-541
        • McCloskey E.
        • Compston J.
        • Cooper C.
        The US FRAX® filter: avoiding confusion or hindering progress?.
        Osteoporos Int. 2010; 21: 885
        • Tosteson A.N.
        • Melton L.J.
        • Dawson-Hughes B.
        • et al.
        Cost-effective osteoporosis treatment thresholds: the United States perspective.
        Osteoporos Int. 2008; 19: 437-447
        • Dawson-Hughes B.
        • Tostoson A.N.A.
        • Melton L.J.
        • et al.
        Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.
        Osteoporos Int. 2008; 19: 449-458
        • Leslie W.D.
        • Tsang J.F.
        • Lix L.M.
        Effect of total hip bone area on osteoporosis diagnosis and fractures.
        J Bone Miner Res. 2008; 23: 1468-1476
        • Dawson-Hughes B.
        • Looker A.C.
        • Tosteson A.N.A.
        • et al.
        The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.
        Osteoporos Int. 2010; 21: 41-52
        • Cummings S.R.
        • Ensrud K.
        • Donaldson M.G.
        • et al.
        The US National Osteoporosis Foundation (NOF) Guidelines: recommendations for pharmacologic treatment.
        IBMS Bone Key. 2008; 5: 137-141
        • Cauley J.A.
        • Robbins J.
        • Chen Z.
        • et al.
        Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial.
        JAMA. 2003; 290: 1729-1738
        • Kanis J.A.
        • Oden A.
        • Johansson H.
        • et al.
        FRAX® and its applications to clinical practice.
        Bone. 2009; 44: 734-743
        • McCloskey E.V.
        • Johansson H.
        • Oden A.
        • et al.
        Ten-year fracture probability identifies women who benefit from clodronate therapy-additional results from a double-blind, placebo-controlled randomized study.
        Osteoporos Int. 2009; 20: 811-817
        • Kanis J.A.
        • Johansson H.
        • Oden A.
        • et al.
        Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
        Bone. 2009; 44: 1049-1054
        • Kanis J.A.
        • Johansson H.
        • Oden A.
        • et al.
        A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX®.
        Bone. 2010; 47: 729-735
        • Kanis J.A.
        • Johansson H.
        • Oden A.
        A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®.
        Osteoporos Int. 2011; 22: 2347-2355
        • Watts N.B.
        • Lewiecki E.M.
        • Bonnick S.L.
        • et al.
        Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis.
        J Bone Miner Res. 2009; 24: 1643-1646
        • Barrett-Conner E.
        • Sajjan S.G.
        • Siris E.S.
        • et al.
        Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA).
        Osteoporos Int. 2008; 19: 607-613
        • Siris E.S.
        • Chen Y.T.
        • Abbott T.A.
        • et al.
        Bone mineral density threshold for pharmacologic intervention to prevent fractures.
        Obstet Gynecol Surv. 2004; 59: 769-771
        • Barrett-Connor E.
        • Sajjan S.G.
        • Miller P.D.
        • et al.
        Rib fracture as an indicator of future fracture risk in postmenopausal women 50–99 years of age: results from the National Osteoporosis Risk Assessment (NORA).
        Osteoporos Int. 2006; 17: S145
        • Ismail A.A.
        • Silman A.J.
        • Reeve J.
        • et al.
        Rib fractures predict incident limb fractures: results from the European prospective osteoporosis study.
        Osteoporos Int. 2006; 17: 41-45
        • Palvanen M.
        • Kannus P.
        • Niemi S.
        • et al.
        Hospital-treated minimal-trauma rib fractures in elderly Finns: long-term trend and projections for the future.
        Osteoporos Int. 2004; 15: 649-653
      12. Gillespie LD, Robertson MC, Lamb SE, et al. 2010 Interventions for preventing falls in older people living in the community (review); The Cochrane Collaboration. Available at: http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD007146/frame.html. Accessed February 24, 2011.

      13. Cameron ID, Murray GR, Gillespie LD, et al. 2010 Interventions for preventing falls in older people in nursing care facilities and hospitals (review). Available at: http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD005465/frame.html. Accessed February 25, 2011.

      14. Howe TE, Rochester L, Jackson A, 2008 exercise for improving balance in older people (review). Available at: http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD004963/frame.html. Accessed February 25, 2011.

        • Grossman J.M.
        • Gordon R.
        • Ranganath V.K.
        • et al.
        American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.
        Arthritis Care Res. 2010; 62: 1515-1526
        • Kanis J.A.
        • Johansson H.
        • Oden A.
        • et al.
        Guidance for the adjustment of FRAX according to the dose of glucocorticoids.
        Osteoporos Int. 2011; 22: 809-816
        • van Staa T.P.
        • Leufkens H.G.
        • Abenhaim L.
        • et al.
        Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.
        Rheumatology(Oxford). 2000; 39 (Kanis article above): 1383-1389
        • Reid D.M.
        • Hughes R.A.
        • Laan R.F.
        • et al.
        Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial.
        J Bone Miner Res. 2000; 15: 1006-1013
        • Michel B.A.
        • Bloch D.A.
        • Wolfe F.
        • et al.
        Fractures in rheumatoid arthritis: an evaluation of associated risk factors.
        J Rheumatol. 1993; 20: 1666-1669
        • Reid I.R.
        Glucocorticoid osteoporosis-mechanisms and management.
        Eur J Endocrinol. 1997; 137: 209-217
        • Cooper C.
        • Coupland C.
        • Mitchell M.
        Rheumatoid arthritis, corticosteroid therapy and hip fracture.
        Ann Rheum Dis. 1995; 54: 49-52
        • De Vries F.
        • Brache M.
        • Leufkens H.G.
        • et al.
        Fracture risk with intermittent high-dose oral glucocorticoid therapy.
        Arthritis Rheum. 2007; 56: 208-214
        • Johnell O.
        • Kanis J.A.
        • Oden A.
        • et al.
        Predictive value of BMD for hip and other fractures.
        J Bone Miner Res. 2005; 20: 1185-1194
        • Kanis J.A.
        • McCloskey E.V.
        • Johansson H.
        • et al.
        A reference standard for the description of osteoporosis.
        Bone. 2008; 42: 467-475
        • Looker A.C.
        • Wahner H.W.
        • Dunn W.L.
        • et al.
        Updated data on proximal femur bone mineral levels of US adults.
        Osteoporos Int. 1998; 8: 468-489
        • Jones G.
        • Nguyen T.
        • Sambrook P.N.
        • et al.
        A longitudinal study of the effect of spinal degenerative disease on bone density in the elderly.
        J Rheumatol. 1995; 22: 932-936
        • Phillipov G.
        • Phillips P.J.
        Skeletal site bone mineral density heterogeneity in women and men.
        Osteoporos Int. 2001; 12: 362-365
        • Schneider D.L.
        • Bettencourt R.
        • Barrett-Connor E.
        Clinical utility of spine bone density in elderly women.
        J Clin Densitom. 2006; 9: 255-260
        • Faulkner K.G.
        • von Stetten E.
        • Miller P.
        Discordance in patient classification using T-scores.
        J Clin Densitom. 1999; 2: 343-350
        • Leslie W.D.
        • Lix L.M.
        • Tsang J.F.
        • et al.
        Single-site vs multisite bone density measurement for fracture prediction.
        Arch Intern Med. 2007; 167: 1641-1647
        • Leslie W.D.
        • Lix L.M.
        Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: derivation and validation of a hybrid system.
        J Bone Miner Res. 2011; 26: 460-467
        • Leslie W.D.
        • Lix L.M.
        • Johansson H.
        • et al.
        Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement.
        Osteoporos Int. 2011; 22: 839-847
        • Leslie W.D.
        • Kovacs C.S.
        • Olszynski W.P.
        • et al.
        Spine-hip T-score difference predicts major osteoporotic fracture risk independent of FRAX®: a population-based report from CAMOS.
        J Clin Densitom. 2011; 11: 123-162